V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260017128 | 260010241 | 1.63 | 65.5 | Curative (C) | 2017-03-20 | 2017-03-27 | ICE + GCSF | 2 | N | 260019019 | IPO |
| 260017129 | 260010243 | 1.88 | 67.8 | Curative (C) | 2020-02-07 | 2020-03-28 | GEMCITABINE + TIP | N | N | 260022120 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 260017130 | 260010248 | 1.79 | 89.4 | Palliative (P) | 2016-03-21 | 2016-03-21 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | N | N | 260022492 | POMB |
| 260017131 | 260010250 | 1.75 | 70.5 | Disease modification (D) | 2015-05-30 | 2015-08-22 | Vinblastine weekly | N | Y | 260014077 | IVA |
| 260017132 | 260012522 | 1.65 | 0 | Disease modification (D) | 2017-07-08 | 2017-07-08 | Rituximab (Maintenance) | 02 | Y | 260010773 | RITUXIMAB |
| 260017133 | 260006450 | 1.63 | 77.7 | Palliative (P) | 2016-10-19 | 2016-11-02 | Rituximab | 02 | N | 260010969 | RITUXIMAB |
| 260017134 | 260006458 | 0 | 65.8 | Palliative (P) | null | 2014-08-28 | Rituximab (SUBCUTANEOUS Maintenance) | null | N | 260011322 | RITUXIMAB |
| 260017135 | 260006461 | null | 79 | Palliative (P) | 2015-05-30 | 2015-08-07 | Rituximab (Maintenance) | N | N | 260011567 | RITUXIMAB |
| 260017136 | 260006464 | 1.65 | 70.3 | Palliative (P) | 2017-03-19 | 2017-09-19 | Rituximab | null | null | 260011668 | RITUXIMAB |
| 260017137 | 260006467 | 1.84 | 107.7 | Disease modification (D) | 2016-09-15 | 2017-01-05 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260011994 | RITUXIMAB |
| 260017138 | 260006470 | 1.76 | null | Radical (R) | 2013-09-08 | 2014-08-20 | Rituximab | 02 | N | 260012051 | RITUXIMAB |
| 260017139 | 260006471 | 1.88 | 68 | Palliative (P) | null | 2015-10-29 | Rituximab | N | N | 260012100 | RITUXIMAB |
| 260017140 | 260006472 | 1.79 | null | Adjuvant (A) | 2018-08-20 | 2018-09-10 | Rituximab (Maintenance) | N | N | 260012162 | RITUXIMAB |
| 260017141 | 260006475 | 1.71 | 99.2 | Disease modification (D) | 2016-11-19 | 2016-11-23 | Rituximab | 02 | N | 260012217 | RITUXIMAB |
| 260017142 | 260006478 | 1.71 | 67.4 | Palliative (P) | 2017-10-12 | 2018-09-15 | Rituximab | N | N | 260012548 | RITUXIMAB |
| 260017143 | 260006481 | 1.8 | 67.1 | Palliative (P) | 2014-11-13 | 2014-11-20 | Rituximab | 02 | N | 260012573 | RITUXIMAB |
| 260017144 | 260006489 | null | 82 | Palliative (P) | 2014-01-23 | 2014-01-23 | Rituximab (Maintenance) | 2 | N | 260012676 | RITUXIMAB |
| 260017145 | 260012559 | 1.75 | 60.9 | Palliative (P) | 2017-07-24 | 2017-07-29 | Rituximab | 2 | N | 260013256 | RITUXIMAB |
| 260017146 | 260006500 | 1.7 | 103 | Palliative (P) | 2015-09-10 | 2016-06-04 | Rituximab | 02 | N | 260013428 | RITUXIMAB |
| 260017147 | 260006514 | 1.7 | 86.3 | Curative (C) | 2015-06-24 | 2015-07-07 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260014565 | RITUXIMAB |
| 260017148 | 260006516 | 1.87 | 66.6 | Curative (C) | 2016-12-05 | 2017-05-11 | Rituximab (Maintenance) | N | N | 260014693 | RITUXIMAB |
| 260017149 | 260006520 | 1.67 | 82.8 | Palliative (P) | null | 2018-01-20 | Rituximab (Maintenance) | N | N | 260014941 | RITUXIMAB |
| 260017150 | 260018417 | null | 66.6 | Disease modification (D) | 2017-03-02 | 2017-12-15 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260014977 | RITUXIMAB |
| 260017151 | 260006524 | 1.81 | 73.4 | Palliative (P) | 2017-12-16 | 2018-05-23 | Rituximab | N | N | 260015169 | RITUXIMAB |
| 260017152 | 260006526 | 1.63 | 0 | Disease modification (D) | 2012-03-12 | 2013-03-11 | Rituximab | null | null | 260015308 | RITUXIMAB |
| 260017153 | 260006527 | 1.77 | null | Disease modification (D) | 2015-04-14 | 2015-06-20 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | Y | 260015314 | RITUXIMAB |
| 260017154 | 260006531 | null | 80 | Curative (C) | 2013-09-19 | 2013-09-24 | Rituximab | N | N | 260015497 | RITUXIMAB |
| 260017155 | 260006534 | null | 105.8 | Disease modification (D) | 2017-11-10 | 2017-11-26 | Rituximab | 2 | N | 260015517 | RITUXIMAB |
| 260017156 | 260006536 | 1.47 | 75.4 | Disease modification (D) | null | 2018-10-18 | Rituximab | N | N | 260015544 | RITUXIMAB |
| 260017157 | 260012596 | 1.6 | null | Palliative (P) | 2018-05-03 | 2018-05-03 | Rituximab | 02 | N | 260015590 | RITUXIMAB |
| 260017158 | 260006543 | 1.53 | 82.8 | Palliative (P) | 2014-12-22 | 2015-06-19 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260015684 | RITUXIMAB |
| 260017159 | 260006546 | 1.67 | 57 | Disease modification (D) | 2015-04-11 | 2016-08-08 | Rituximab | N | N | 260015694 | RITUXIMAB |
| 260017160 | 260006549 | 1.85 | 90 | Curative (C) | 2015-05-26 | 2015-05-26 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260015702 | RITUXIMAB |
| 260017161 | 260006551 | 1.79 | 80 | null | 2013-09-13 | 2013-09-15 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260015706 | RITUXIMAB |
| 260017162 | 260012608 | 1.66 | 38.6 | null | 2019-02-24 | 2019-03-14 | Rituximab | null | null | 260015737 | RITUXIMAB |
| 260017163 | 260006559 | null | null | Curative (C) | 2018-07-15 | 2019-07-23 | Rituximab (Maintenance) | null | null | 260015800 | RITUXIMAB |
| 260017164 | 260006563 | 1.6 | 93.8 | Curative (C) | 2018-01-11 | 2018-01-18 | Rituximab | 2 | N | 260015829 | RITUXIMAB |
| 260017165 | 260006566 | null | 79 | Disease modification (D) | 2017-05-08 | 2017-07-11 | Rituximab | N | N | 260015840 | RITUXIMAB |
| 260017166 | 260006567 | null | 78 | Adjuvant (A) | null | 2018-06-12 | Rituximab | N | N | 260015845 | RITUXIMAB |
| 260017167 | 260012618 | 0 | 48.7 | Adjuvant (A) | 2016-07-12 | 2016-07-19 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260015850 | RITUXIMAB |
| 260017168 | 260006573 | 1.79 | 59 | Disease modification (D) | 2014-05-15 | 2014-11-19 | Rituximab | N | null | 260015868 | RITUXIMAB |
| 260017169 | 260006580 | null | 93 | Palliative (P) | 2016-08-13 | 2017-02-03 | Rituximab | N | null | 260015955 | RITUXIMAB |
| 260017170 | 260006581 | 1.59 | 75.2 | Palliative (P) | 2018-03-17 | 2018-10-29 | Rituximab (INTRAVENOUS Maintenance) | N | N | 260015964 | RITUXIMAB |
| 260017171 | 260006589 | null | null | Disease modification (D) | 2015-08-14 | 2015-08-30 | Rituximab | 2 | null | 260016063 | RITUXIMAB |
| 260017172 | 260006595 | null | 84.5 | Disease modification (D) | 2013-08-30 | 2013-09-02 | Rituximab | N | N | 260016181 | RITUXIMAB |
| 260017173 | 260006600 | 1.85 | 0 | Palliative (P) | 2015-05-18 | 2015-12-12 | Rituximab | 2 | Y | 260016233 | RITUXIMAB |
| 260017174 | 260006602 | 1.65 | 104 | Palliative (P) | 2017-12-22 | 2017-12-23 | Rituximab | 02 | N | 260016263 | RITUXIMAB |
| 260017175 | 260006603 | 1.7 | 96 | Palliative (P) | 2016-04-25 | 2016-11-23 | Rituximab (Maintenance) | N | N | 260016267 | RITUXIMAB |
| 260017176 | 260006606 | 1.75 | 76.4 | Curative (C) | 2018-05-31 | 2018-05-31 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260016279 | RITUXIMAB |
| 260017177 | 260006608 | null | 82 | Adjuvant (A) | 2019-05-18 | 2019-05-18 | Rituximab | 02 | N | 260016286 | RITUXIMAB |